Genenta Science S.p.A. (GNTA)
NASDAQ: GNTA · Real-Time Price · USD
4.165
-0.175 (-4.03%)
May 12, 2025, 4:00 PM - Market closed
Genenta Science Employees
Genenta Science had 13 employees as of December 31, 2024. The number of employees decreased by 1 or -7.14% compared to the previous year.
Employees
13
Change (1Y)
-1
Growth (1Y)
-7.14%
Revenue / Employee
n/a
Profits / Employee
-$709,780
Market Cap
76.18M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 13 | -1 | -7.14% |
Dec 31, 2023 | 14 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
GNTA News
- 4 days ago - Genenta Science, SpA Announces Participation in the D. Boral Capital Inaugural Global Conference - Newsfile Corp
- 5 days ago - Genenta and Anemocyte announce a collaboration for the manufacturing of starting materials for cutting-edge cell-based therapies - GlobeNewsWire
- 27 days ago - Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar - GlobeNewsWire
- 7 weeks ago - Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates - GlobeNewsWire
- 3 months ago - TOP ITALIAN AND U.S. LIFE SCIENCES EXECUTIVES AND ITALIAN GOVERNMENT LEADERS SHARED BUSINESS SUCCESS STORIES WITH INVESTORS AT "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE - PRNewsWire
- 4 months ago - Genenta Strengthens Agreement with AGC Biologics to Boost Cell Therapy Manufacturing - GlobeNewsWire
- 4 months ago - ITALIAN TRADE AGENCY TO HOST "ITALY ON THE MOVE 2025" SIDE EVENT DURING J.P. MORGAN HEALTHCARE CONFERENCE - PRNewsWire
- 7 months ago - Genenta's CEO to present at the U.S. Senate meeting on “Cross-Border Investments and Strategies in the Biotechnology Sector: A Transatlantic Perspective” - GlobeNewsWire